The Situation of Cancer Treatment in Ethiopia: Challenges and Opportunities.
Black Lion Specialized Hospital
Cancer
Challenges
Ethiopia
Opportunities
Journal
Journal of cancer prevention
ISSN: 2288-3649
Titre abrégé: J Cancer Prev
Pays: Korea (South)
ID NLM: 101615965
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
07
02
2019
revised:
21
03
2019
accepted:
21
03
2019
entrez:
18
4
2019
pubmed:
18
4
2019
medline:
18
4
2019
Statut:
ppublish
Résumé
Less attention is given to cancer treatment and control in Ethiopia. To investigate the challenges and opportunities facing cancer treatment services in Ethiopia. A purposive sampling technique was applied to recruit the study subjects from Black Lion Specialized Hospital Oncology Department. A semi-structured interview guide was used to investigate challenges and opportunities in oncology service in Ethiopia. Data was transcribed and coded by two independent coders and analyzed thematically in reference to the objectives. Fifteen professionals from four different disciplines were interviewed on opportunities and challenges facing cancer treatment in Ethiopia. Out of these respondents 3 were senior clinical oncologists while 4 individuals were senior oncology residents. The rest were 2 medical Physicists, 2 radiotherapy technologists and 4 oncology nurses. Majority (80%) of the respondents were males. We demonstrate that the challenges of cancer treatment service in Ethiopia emanate from the patients themselves, the administrating body, the professionals, and the technology limitations. In general, the result of this study was grouped under the following five themes: Customer-related challenges, provider-related challenges, facility-related challenges, technology-related challenges and the opportunities. Several assignments are waiting for the policy makers, the professionals, the communities and other concerned bodies to combat the alarmingly growing burden of cancer in Ethiopia. Escalating the awareness of the general population about cancer, expanding well-developed diagnostic and treatment centers, and producing well-trained competent oncology professionals are the forefront challenges in combating cancer in Ethiopia.
Sections du résumé
BACKGROUND
BACKGROUND
Less attention is given to cancer treatment and control in Ethiopia.
METHODS
METHODS
To investigate the challenges and opportunities facing cancer treatment services in Ethiopia. A purposive sampling technique was applied to recruit the study subjects from Black Lion Specialized Hospital Oncology Department. A semi-structured interview guide was used to investigate challenges and opportunities in oncology service in Ethiopia. Data was transcribed and coded by two independent coders and analyzed thematically in reference to the objectives.
RESULTS
RESULTS
Fifteen professionals from four different disciplines were interviewed on opportunities and challenges facing cancer treatment in Ethiopia. Out of these respondents 3 were senior clinical oncologists while 4 individuals were senior oncology residents. The rest were 2 medical Physicists, 2 radiotherapy technologists and 4 oncology nurses. Majority (80%) of the respondents were males. We demonstrate that the challenges of cancer treatment service in Ethiopia emanate from the patients themselves, the administrating body, the professionals, and the technology limitations. In general, the result of this study was grouped under the following five themes: Customer-related challenges, provider-related challenges, facility-related challenges, technology-related challenges and the opportunities.
CONCLUSIONS
CONCLUSIONS
Several assignments are waiting for the policy makers, the professionals, the communities and other concerned bodies to combat the alarmingly growing burden of cancer in Ethiopia. Escalating the awareness of the general population about cancer, expanding well-developed diagnostic and treatment centers, and producing well-trained competent oncology professionals are the forefront challenges in combating cancer in Ethiopia.
Identifiants
pubmed: 30993093
doi: 10.15430/JCP.2019.24.1.33
pii: jcp-24-033
pmc: PMC6453587
doi:
Types de publication
Journal Article
Langues
eng
Pagination
33-42Déclaration de conflit d'intérêts
CONFLICTS OF INTEREST No potential conflicts of interest were disclosed.
Références
Semin Oncol. 2001 Apr;28(2):210-6
pubmed: 11301385
Acta Oncol. 2001;40(7):844-8
pubmed: 11859984
Support Care Cancer. 2003 May;11(5):286-93
pubmed: 12690539
Lancet. 2003 Sep 13;362(9387):903-8
pubmed: 13678979
Breast J. 2006 Jan-Feb;12 Suppl 1:S27-37
pubmed: 16430396
Ann Oncol. 2006 Jun;17 Suppl 8:viii9-viii14
pubmed: 16801342
Lancet Oncol. 2006 Jul;7(7):584-95
pubmed: 16814210
ScientificWorldJournal. 2006 Jul 07;6:781-90
pubmed: 16830050
BMC Cancer. 2006 Nov 26;6:271
pubmed: 17125524
Am Fam Physician. 2008 Feb 1;77(3):311-9
pubmed: 18297955
Pharm Res. 2008 Sep;25(9):2097-116
pubmed: 18626751
Int J Behav Med. 2008;15(4):289-92
pubmed: 19005928
Nat Clin Pract Oncol. 2009 Mar;6(3):136-7
pubmed: 19048009
Indian J Cancer. 2009 Jul-Sep;46(3):252-3
pubmed: 19574687
Breast J. 2010 Jan-Feb;16(1):101-2
pubmed: 19825004
Lancet. 2010 Oct 2;376(9747):1186-93
pubmed: 20709386
Lancet. 2010 Nov 27;376(9755):1827
pubmed: 21111907
Afr Health Sci. 2011 Mar;11(1):48-57
pubmed: 21572857
Future Oncol. 2011 Oct;7(10):1213-22
pubmed: 21992732
East Afr J Public Health. 2011 Mar;8(1):52-7
pubmed: 22066285
Blood. 2012 May 31;119(22):5078-87
pubmed: 22461494
Science. 2012 Sep 21;337(6101):1482-7
pubmed: 22997325
Lancet Oncol. 2013 Apr;14(4):e168-75
pubmed: 23561748
PLoS One. 2013 Oct 30;8(10):e78411
pubmed: 24205226
BMC Public Health. 2014 Oct 22;14:1096
pubmed: 25339243
Health Expect. 2016 Aug;19(4):854-67
pubmed: 26205470
Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1495-506
pubmed: 26359465
Front Oncol. 2016 Jun 28;6:160
pubmed: 27446806
J Glob Oncol. 2016 Dec 21;3(3):194-200
pubmed: 28717760
PLoS One. 2017 Jul 25;12(7):e0181415
pubmed: 28742851